Cover Image

US population qualifying for aspirin use for primary prevention of cardiovascular disease

Objective: Aspirin has been used for primary prevention of atherosclerotic cardiovascular disease (ASCVD) for decades, but this indication has become controversial with recent trial data. The 2022 US Preventive Services Task Force (USPSTF) provided a recommendation to consider aspirin use for primar...

Full description

Saved in:

Bibliographic Details
Main Authors:	Athena L. Huang (Author), Ann Marie Navar (Author), Colby Ayers (Author), Anand Rohatgi (Author), Erin D. Michos (Author), Salim S. Virani (Author), Parag Joshi (Author), Eric D. Peterson (Author), Amit Khera (Author)
Format:	Book
Published:	Elsevier, 2024-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
by: Athena L. Huang, MD, et al.
Published: (2023)

U.S. population at increased risk of severe illness from COVID-19
by: Ezimamaka Ajufo, et al.
Published: (2021)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis
by: Kayla A. Riggs, et al.
Published: (2022)

Corrigendum to U.S. Population at Increased Risk of Severe Illness from COVID-19
by: Ezimamaka Ajufo, BM BCh, et al.
Published: (2021)

Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology
by: Amit Khera, et al.
Published: (2020)

County-level phenomapping to identify disparities in cardiovascular outcomes: An unsupervised clustering analysis
by: Matthew W. Segar, et al.
Published: (2020)

Lipid-lowering therapy and LDL-C control for primary prevention in persons with diabetes across 90 health systems in the United States
by: Emily Decicco, et al.
Published: (2023)

Income disparity and utilization of cardiovascular preventive care services among U.S. adults
by: Andi Shahu, et al.
Published: (2021)

Aspirin use for primary prevention among US adults with and without elevated Lipoprotein(a)
by: Alexander C. Razavi, et al.
Published: (2024)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
by: Yixi Zhao, et al.
Published: (2021)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
by: Safi U. Khan, et al.
Published: (2020)

Preeclampsia and aspirin
by: Tae Gyu Ahn, et al.
Published: (2023)

Zanimivosti: aspirin
by: Uredništvo/Editorial Board
Published: (1992)

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
by: Xintian Lyu, BS, et al.
Published: (2023)

Same evidence, varying viewpoints: Three questions illustrating important differences between United States and European cholesterol guideline recommendations
by: David I. Feldman, et al.
Published: (2020)

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006-2015
by: Victor Okunrintemi, et al.
Published: (2021)

Alleviating Aspirin-Induced Gastric Injury by Binding Aspirin to β-Lactoglobulin
by: Chen J, et al.
Published: (2022)

Erratum to "Cardiovascular Mortality after Intensive LDL-Cholesterol Lowering: Does Baseline LDL-Cholesterol Really Matter?" [American Journal of Preventive Cardiology 1C (2020) 100013]
by: Safi U. Khan, et al.
Published: (2021)

Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop
by: Ann Marie Navar, et al.
Published: (2022)

Aspirin and oral surgery
by: Dorota Ochyra, et al.
Published: (2018)

Aspirin in dermatology: Revisited
by: Aditya Kumar Bubna
Published: (2015)

Aspirin and oral surgery
by: Dorota Ochyra, et al.
Published: (2018)

Reye Syndrome and Aspirin
by: J Gordon Millichap
Published: (1987)

Lifelong prevention of atherosclerotic cardiovascular disease (ASCVD) through LDL-C control - Means and cost/benefit of sustained very low lifetime LDL-C targets
by: Mayank Dalakoti, et al.
Published: (2024)

The college students' perspective on what makes an educator well-qualified
by: John Mark R. Asio, et al.
Published: (2019)

A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study
by: Matthew K. Hoffman, et al.
Published: (2017)

Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey
by: Javier Valero-Elizondo, et al.
Published: (2022)

RELATIONSHIP BETWEEN SOCIOECONOMIC STATUS, CORONARY ARTERY CALCIUM AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A MULTI-COHORT STUDY
by: Taylor Triana, MD, MBA, et al.
Published: (2023)

Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease
by: Danh Q. Nguyen, et al.
Published: (2024)

Which people should take aspirin for primary prevention of cardiovascular disease?
by: Lozano R, et al.
Published: (2015)

Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology
by: M. M. Tanashyan, et al.
Published: (2021)

Aspirin and endometrial cancer risk
by: Theodore M. Brasky, et al.
Published: (2016)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015)

Acetaminophen, Aspirin, and Caffeine for Migraine
by: J Gordon Millichap
Published: (1998)

Aspirin Resistance and Its Importance
by: Aru W Sudoyo
Published: (2016)

Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention
by: Petal Elder, et al.
Published: (2020)

Aspects of psychosomatic disorders in highly qualified athletes
by: I. N. Mitin, et al.
Published: (2020)

The Incidence and Methods for Detecting Aspirin Resistance in Pediatric Patients
by: Poparn H, et al.
Published: (2024)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
by: Xie W, et al.
Published: (2019)